NCT05985668 is a clinical trial in Platelet Function Disorder, sponsored by Region Stockholm.

Who is sponsoring NCT05985668?

NCT05985668 is sponsored by Region Stockholm.

What condition does NCT05985668 study?

NCT05985668 studies Platelet Function Disorder, Platelet Disorder, Thrombocytopathy.

Is NCT05985668 still recruiting?

NCT05985668 is currently recruiting now. Last updated 4 December 2023.

Last reviewed 2023-12-04 · How we verify

NCT05985668

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Towards Improved Diagnostics for Suspected Platelet Function Disorders

Recruiting now Last updated 4 December 2023

What this trial tests

trial in Platelet Function Disorder in 140 participants. Currently enrolling.

Timeline

5 September 2023

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Region Stockholm
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	140
Start date	5 September 2023
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across Sweden

Conditions studied

Platelet Function Disorder — all drugs for Platelet Function Disorder →
Platelet Disorder — all drugs for Platelet Disorder →
Thrombocytopathy — all drugs for Thrombocytopathy →

Sponsor

Region Stockholm — full company profile →

Who can join

12 Months and older, any sex, with Platelet Function Disorder or Platelet Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to improve platelet function testing during bleeding investigations. To this end, the study will evaluate the diagnostic accuracy of novel platelet function tests in patients with confirmed or suspected platelet function disorders. Study participants will be recruited from patients that are referred to or treated at the Coagulation Unit, Karolinska University Hospital, and Pediatric Coagulation Unit, Astrid Lingren Children's Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Region Stockholm trials

Trials by the same sponsor.

NCT06304363 — Braining - Evaluation of Acute Effects of Physical Exercise · NA · not yet recruiting
NCT07089771 — Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy · NA · not yet recruiting
NCT07503951 — Cognitive Behavior Therapy in Psychiatric Inpatient Care · NA · not yet recruiting
NCT07434219 — A Group Based Psychoeducational Intervention for Partners of Child Sexual Abuse Material Offenders. · NA · not yet recruiting
NCT07464730 — Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05985668 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Stockholm
Last refreshed: 4 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05985668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing